Scarica l'app Stockscreener
7.86
2.24%
-0.18
Dopo l'orario di chiusura:
7.82
-0.04
-0.51%
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Quantum BioPharma’s ‘unbuzzd’ Launches in Puerto Rico - TipRanks
Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico - GlobeNewswire
Clinical-Backed Hangover Cure unbuzzd Hits Walmart, Costco: Game-Changing Launch - Stock Titan
Quantum Biopharma to Jointly Study Demyelination Imaging Technique With Massachusetts Hospital - MarketScreener
Quantum BioPharma Announces Joint Clinical Study With - GlobeNewswire
Game-Changing MS Detection: Quantum's New PET Technology Could Outperform Traditional MRI - Stock Titan
Quantum BioPharma completes $5 million funding round By Investing.com - Investing.com Canada
Quantum BioPharma in Joint Clinical Study With Massachusetts Hospital to Assess PET Imaging - MarketScreener
Quantum BioPharma completes $5 million funding round - Investing.com
Quantum BioPharma Secures Final Tranche of $5 Million Financing - TipRanks
Quantum Biopharma Announces Closing of Final $2.42 Million - GlobeNewswire
Quantum BioPharma Closes $5M Deal While Unveiling Revolutionary Emergency Alcohol Treatment - Stock Titan
Quantum BioPharma Invests $65K in Enhanced Investor Communications Strategy - Stock Titan
Promising Biotech Stocks To Watch Now – March 28th - Defense World
Quantum BioPharma reports progress in drug trials By Investing.com - Investing.com South Africa
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Monolithic Power Systems, Inc. (MPWR) - The Globe and Mail
Quantum BioPharma pushes clinical pipeline after rebranding - Green Market Report
Quantum BioPharma reports progress in drug trials - Investing.com
Quantum BioPharma stock soars on removal of uncertainty related to going concern By Investing.com - Investing.com South Africa
Quantum BioPharma stock soars on removal of uncertainty related to going concern - Investing.com Australia
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern - Bluefield Daily Telegraph
Quantum Biopharma Achieves Financial Milestone: Going Concern Warning Lifted as Clinical Trials Show Promise - Stock Titan
Quantum BioPharma Reports Strong 2024 Financials and Advances in Clinical Trials - TipRanks
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working - Bluefield Daily Telegraph
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern - GlobeNewswire
Quantum Biopharma Achieves Major Turnaround: Going Concern Lifted as Cash Position Strengthens - Stock Titan
BiomednewsbreaksQuantum Biopharma Ltd. (NASDAQ: QNTM) Reports Q4 And Full-Year 2024 Financial Results, Highlights Breakthroughs In Alcohol Detox And MS Treatments - MENAFN.COM
Quantum BioPharma adds Terry Lynch to its board By Investing.com - Investing.com South Africa
SPY ETF News, 3/27/2025 - The Globe and Mail
AgriForce Growing Systems to Participate in Entrepreneurs’ Organization Event at Morgan Stanley’s New York City Offices - The Globe and Mail
Quantum BioPharma adds Terry Lynch to its board - Investing.com India
Quantum BioPharma Strengthens Board with Terry Lynch Appointment - TipRanks
Quantum Biopharma Announces Leading Crusader Against Naked - GlobeNewswire
Market Integrity Champion Terry Lynch Strengthens Quantum BioPharma Leadership - Stock Titan
3 Reasons to Sell RELL and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma's Licensee Introduces New Alcohol Detox Packs in the US - MarketScreener
Quantum BioPharma (QNTM) Stock Rallies Following Key Business Development - Stocks Telegraph
Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing - CoinMarketCap
Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd™ Alcohol Detox Product Lineup for Retail Sales - Quantisnow
Global Weather Concerns Support Coffee Prices - The Globe and Mail
Quantum BioPharma Ltd expected to post a loss of 80 cents a shareEarnings Preview - TradingView
2 ‘Strong Buy’ Tech Stocks Poised for 81% to 110% Gains, According to Wall Street - The Globe and Mail
Every Plug Power Investor Should Keep an Eye on This Number - The Globe and Mail
Sandpiper Asset Management selling at Extendicare (EXE) - The Globe and Mail
Quantum BioPharma Ltd - Stockhouse Publishing
Quantum BioPharma Boosts Crypto Holdings to $3.5M, Eyes Digital Transactions - TradingPedia
Quantum BioPharma Ltd. Expands Cryptocurrency Holdings by $1.5 Million, Totaling $3.5 Million in Bitcoin and Alternatives - Nasdaq
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies - The Manila Times
Quantum BioPharma Continues to Grow Its Crypto Assets and - GlobeNewswire
Quantum Biopharma Continues To Grow Its Crypto Assets And Diversify Its Treasury With The Purchase Of Another USD $1,500,000 Worth Of Bitcoin (BTC) And Other Cryptocurrencies - MENAFN.COM
Quantum BioPharma Doubles Down on Crypto Strategy: Adds $1.5M in Bitcoin to Treasury - StockTitan
Denison Announces Appointment of Former OPG CEO Ken Hartwick to its Board of Directors - The Globe and Mail
Cannabis Stocks To Follow Today – March 18th - Defense World
GIS Earnings: Macro Issues Weigh Down General Mills Stock - The Globe and Mail
Quantum BioPharma Unaware of Any Material Change - Newsfile
Public market insider buying at National Bank of Canada (NA) - The Globe and Mail
The Smartest Vanguard ETF to Buy With $1,000 Right Now - The Globe and Mail
3 Reasons SEM is Risky and 1 Stock to Buy Instead - The Globe and Mail
Why Concrete Pumping (BBCP) Stock Is Falling Today - The Globe and Mail
Quantum BioPharma Provides Corporate Update - Yahoo Finance
3 Market-Beating Stocks to Target This Week - The Globe and Mail
9.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):